BridgeMD
New treatment option for Vertigo
Official title Evaluation of Nystagmus Examination Using Wearable AR Glasses in Vertigo Patients
ClinicalTrials.gov ID: NCT07238387
What this study is testing
- What it's testing
- Background and Purpose: Vertigo is common in emergency and outpatient settings, yet standard oculomotor testing usually requires dedicated equipment and exam rooms. This study evaluates whether nystagmus examinations performed with wearable augmented-reality (AR) glasses are equivalent to conventional examination-room testing for classifying central vs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults ≥18 years with vertigo/dizziness suggestive of a central or peripheral vestibular disorder.
- Able to complete both AR-based and conventional oculomotor testing during the same visit (with \~30-minute washout).
- Provide written informed consent.
- Adequate vision for eye-tracking and calibration (e.g., corrected visual acuity ≥20/40 in each eye).
- Willing and able to return for the follow-up visit.
You likely can't join if
- Use of vestibular-suppressant medications within 24 hours prior to testing (e.g., benzodiazepines, antihistamines, anticholinergics).
- Ocular conditions that would interfere with reliable eye tracking (e.g., corrected visual acuity \<20/40, dense cataract, severe ptosis/strabismus...
- History of photosensitive epilepsy or seizure disorder triggered by visual stimuli.
- Severe motion sickness/cybersickness or inability to tolerate the AR headset.
- Significant cognitive impairment or psychiatric condition precluding informed consent or protocol compliance.
- Pregnant or breastfeeding (per investigator judgment and IRB policy).
See the full eligibility criteria
- Adults ≥18 years with vertigo/dizziness suggestive of a central or peripheral vestibular disorder.
- Able to complete both AR-based and conventional oculomotor testing during the same visit (with \~30-minute washout).
- Provide written informed consent.
- Adequate vision for eye-tracking and calibration (e.g., corrected visual acuity ≥20/40 in each eye).
- Willing and able to return for the follow-up visit.
- Use of vestibular-suppressant medications within 24 hours prior to testing (e.g., benzodiazepines, antihistamines, anticholinergics).
- Ocular conditions that would interfere with reliable eye tracking (e.g., corrected visual acuity \<20/40, dense cataract, severe ptosis/strabismus, active ocular infection/inflammation).
- History of photosensitive epilepsy or seizure disorder triggered by visual stimuli.
- Severe motion sickness/cybersickness or inability to tolerate the AR headset.
- Significant cognitive impairment or psychiatric condition precluding informed consent or protocol compliance.
- Pregnant or breastfeeding (per investigator judgment and IRB policy).
- Any other condition that, in the investigator's opinion, would make participation unsafe or confound study results.
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung, Taiwan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung, Taiwan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.